Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $32,144 | 7 | 96.4% |
| Travel and Lodging | $622.65 | 2 | 1.9% |
| Food and Beverage | $573.02 | 6 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $9,071 | 1 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $7,023 | 3 | $0 (2023) |
| Boehringer Ingelheim International GmbH | $6,300 | 1 | $0 (2023) |
| Novo Nordisk Inc | $6,000 | 1 | $0 (2018) |
| Janssen Global Services, LLC | $4,652 | 4 | $0 (2017) |
| Medtronic Vascular, Inc. | $184.14 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $110.00 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,071 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($9,071) |
| 2023 | $8,700 | 2 | Boehringer Ingelheim International GmbH ($6,300) |
| 2022 | $3,000 | 1 | Novartis Pharmaceuticals Corporation ($3,000) |
| 2021 | $1,623 | 1 | NOVARTIS PHARMACEUTICALS CORPORATION ($1,623) |
| 2020 | $96.39 | 1 | Medtronic Vascular, Inc. ($96.39) |
| 2019 | $110.00 | 3 | Merck Sharp & Dohme Corporation ($110.00) |
| 2018 | $6,000 | 1 | Novo Nordisk Inc ($6,000) |
| 2017 | $4,739 | 5 | Janssen Global Services, LLC ($4,652) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $9,071.25 | General |
| 11/16/2023 | Boehringer Ingelheim International GmbH | — | Consulting Fee | Cash or cash equivalent | $6,300.00 | General |
| 01/19/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | LEQVIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,400.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/17/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | LEQVIO (Drug) | Consulting Fee | Cash or cash equivalent | $1,623.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/08/2020 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $96.39 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/19/2019 | Merck Sharp & Dohme Corporation | MK-1242 (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2018 | Novo Nordisk Inc | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
| 08/16/2017 | Janssen Global Services, LLC | — | Consulting Fee | Cash or cash equivalent | $3,750.00 | General |
| 08/16/2017 | Janssen Global Services, LLC | — | Travel and Lodging | In-kind items and services | $594.65 | General |
| 08/16/2017 | Janssen Global Services, LLC | — | Food and Beverage | In-kind items and services | $278.88 | General |
| 08/16/2017 | Janssen Global Services, LLC | — | Travel and Lodging | Cash or cash equivalent | $28.00 | General |
| 02/07/2017 | Medtronic Vascular, Inc. | Reveal LINQ (Device) | Food and Beverage | In-kind items and services | $87.75 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 97 | 187 | $123,988 | $25,326 |
| 2022 | 2 | 97 | 189 | $136,748 | $28,723 |
| 2021 | 2 | 64 | 154 | $112,060 | $23,501 |
| 2020 | 2 | 165 | 305 | $148,584 | $36,052 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 65 | 126 | $108,738 | $20,487 | 18.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 32 | 61 | $15,250 | $4,839 | 31.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 69 | 146 | $125,998 | $25,349 | 20.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 43 | $10,750 | $3,374 | 31.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 48 | 120 | $103,560 | $20,752 | 20.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 34 | $8,500 | $2,749 | 32.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 80 | 118 | $101,834 | $20,765 | 20.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 85 | 187 | $46,750 | $15,286 | 32.7% |
About Dr. Daniel Mark, MD
Dr. Daniel Mark, MD is a Cardiovascular Disease healthcare provider based in Durham, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881778769.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Mark, MD has received a total of $33,340 in payments from pharmaceutical and medical device companies, with $9,071 received in 2024. These payments were reported across 15 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($32,144).
As a Medicare-enrolled provider, Mark has provided services to 423 Medicare beneficiaries, totaling 835 services with total Medicare billing of $113,602. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Location Durham, NC
- Active Since 10/25/2006
- Last Updated 10/04/2007
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1881778769
Products in Payments
- LEQVIO (Drug) $7,023
- Reveal LINQ (Device) $184.14
- MK-1242 (Drug) $110.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Durham
R. Williams, M.d, M.D
Cardiovascular Disease — Payments: $3.3M
Jonathan Piccini, M.d., M.h.s, M.D., M.H.S
Cardiovascular Disease — Payments: $1.3M
David Kong, M.d., A.m., D.m.t, M.D., A.M., D.M.T
Cardiovascular Disease — Payments: $576,585
Adrian Hernandez, M.d, M.D
Cardiovascular Disease — Payments: $535,728
Chris Granger, M.d, M.D
Cardiovascular Disease — Payments: $510,675
Christopher Kontos, M.d, M.D
Cardiovascular Disease — Payments: $473,112